COVID‐19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID‐19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases

Published:2020-12-17 Issue:2 Volume:60 Page:253-254
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Ayhan Erhan¹^ORCID,Öztürk Murat²,An İsa³^ORCID,Bekçİbaşi Muhammed⁴

Affiliation:

1. Department of Dermatology University of Health Sciences Gazi Yaşargil Education and Research Hospital Diyarbakır Turkey

2. Department of Dermatology Van Education and Research Hospital Van Turkey

3. Department of Dermatology Şanlıurfa Education and Research Hospital Şanlıurfa Turkey

4. Department of Infectious Diseases and Clinical Microbiology Bismil State Hospital Diyarbakır Turkey

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.15379

Reference5 articles.

1. Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety

2. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis

3. Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab

4. Chronic spontaneous urticaria exacerbation in a patient with COVID‐19: rapid and excellent response to omalizumab

5. COVID‐19 in a patient with severe asthma treated with Omalizumab

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Omalizumab Therapy in Patients with Chronic Spontaneous Urticaria: Does it Increase the Risk of COVID-19?;Dermatology Practical & Conceptual;2023-07-31

2. The Frequency and Severity of COVID-19 in Patients Receiving Biological Agents and Risk Factors: Experience of an Allergy Clinic;Asthma Allergy Immunology;2023-04-07

3. The effect of COVID-19 on patients recieving omalizumab treatment;Revue Française d'Allergologie;2023-03

4. The course of COVID-19 in patients with chronic spontaneous urticaria receiving omalizumab treatment;Revue Française d'Allergologie;2022-12

5. Safely use of omalizumab during SARS‐CoV ‐2 infection in patients with chronic spontaneous urticaria;Journal of Cosmetic Dermatology;2022-11-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3